Kurt Lackovic

CEO, Cancer Trials Australia

Dr. Lackovic is leading Cancer Trials Australia (CTA) a highly effective member based clinical trial network and site service organization, which has provided clinical trial administrative support to its members for over 20 years. Since its inception in 1993, CTA has administered the start-up and management of over 1,300 oncology clinical trials, sponsored by over 250 different organizations that have recruited in excess of 8,000 patients. CTA administers oncology clinical trials that range from first-time-in-human trials to large scale Phase Ill trials. With 26 members throughout Victoria, NSW, South Australia and Western Australia, collaboration across these members provides a great opportunity for sponsors to conduct multi-site clinical trials, accruing significant patient numbers quickly, despite Australia's relatively small population.